Silent
Missense
Nonsense
Frequency of SNVs in pancancer level
| Cancer | Full Name | Mutation | Mutation Type | Sample Number |
|---|---|---|---|---|
| BLCA | Bladder urothelial carcinoma | D96G | Missense | 1 |
| BLCA | Bladder urothelial carcinoma | L88L | Silent | 1 |
| BLCA | Bladder urothelial carcinoma | S35S | Silent | 1 |
| COAD | Colon adenocarcinoma | F196C | Missense | 1 |
| COAD | Colon adenocarcinoma | K125T | Missense | 1 |
| KIRC | Kidney renal clear cell carcinoma | K205K | Silent | 1 |
| LIHC | Liver hepatocellular carcinoma | Q32R | Missense | 1 |
| LUAD | Lung adenocarcinoma | D61Y | Missense | 1 |
| LUAD | Lung adenocarcinoma | S8L | Missense | 1 |
| LUAD | Lung adenocarcinoma | T87T | Silent | 1 |
| SARC | Sarcoma | Y219* | Nonsense | 1 |
| SKCM | Skin Cutaneous Melanoma | A46A | Silent | 1 |
| SKCM | Skin Cutaneous Melanoma | P228S | Missense | 1 |
| STAD | Stomach adenocarcinoma | R23Q | Missense | 1 |
| STAD | Stomach adenocarcinoma | S229S | Silent | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | P136P | Silent | 1 |
Mutational percentage of Silent, Missense and Nonsense for various cancers
Summary of mutation in pancancer level
| Cancer | Full Name | # Sample | % Silent | % Missense | % Nonsense |
|---|---|---|---|---|---|
| BLCA | Bladder urothelial carcinoma | 394 | 28.6 | 12.5 | 0 |
| BRCA | Breast invasive carcinoma | 976 | 0 | 0 | 0 |
| CESC | Cervical and endocervical cancers | 194 | 0 | 0 | 0 |
| COAD | Colon adenocarcinoma | 367 | 0 | 25 | 0 |
| ESCA | Esophageal carcinoma | 185 | 0 | 0 | 0 |
| GBM | Glioblastoma multiforme | 283 | 0 | 0 | 0 |
| HNSC | Head and Neck squamous cell carcinoma | 511 | 0 | 0 | 0 |
| KIRC | Kidney renal clear cell carcinoma | 476 | 14.3 | 0 | 0 |
| KIRP | Kidney renal papillary cell carcinoma | 282 | 0 | 0 | 0 |
| LAML | Acute Myeloid Leukemia | 192 | 0 | 0 | 0 |
| LGG | Brain Lower Grade Glioma | 516 | 0 | 0 | 0 |
| LIHC | Liver hepatocellular carcinoma | 373 | 0 | 12.5 | 0 |
| LUAD | Lung adenocarcinoma | 533 | 14.3 | 25 | 0 |
| LUSC | Lung squamous cell carcinoma | 177 | 0 | 0 | 0 |
| OV | Ovarian serous cystadenocarcinoma | 465 | 0 | 0 | 0 |
| PAAD | Pancreatic adenocarcinoma | 126 | 0 | 0 | 0 |
| PCPG | Pheochromocytoma and Paraganglioma | 179 | 0 | 0 | 0 |
| PRAD | Prostate adenocarcinoma | 498 | 0 | 0 | 0 |
| READ | Rectum adenocarcinoma | 122 | 0 | 0 | 0 |
| SARC | Sarcoma | 247 | 0 | 0 | 100 |
| SKCM | Skin Cutaneous Melanoma | 290 | 14.3 | 12.5 | 0 |
| STAD | Stomach adenocarcinoma | 393 | 14.3 | 12.5 | 0 |
| TGCT | Testicular Germ Cell Tumors | 147 | 0 | 0 | 0 |
| THCA | Thyroid carcinoma | 495 | 0 | 0 | 0 |
| THYM | Thymoma | 119 | 0 | 0 | 0 |
| UCEC | Uterine Corpus Endometrial Carcinoma | 248 | 14.3 | 0 | 0 |